Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized study that will enroll patients scheduled for an endoscopic biopsy of a
pancreas lesion to be in the heparin or saline group during the procedure.
The purpose of this study is to examine the effect of blood contamination, heparin priming of
the fine needle biopsies, and pass number on tumor tissue quality in fine needle biopsies.
The hypothesis for this study is that fine needle biopsy tissue quality of pancreatic masses
decreases with increasing pass number due to blood contamination; this blood contamination
can be ameliorated with priming of the needle with an anticoagulant such as heparin.